<p>Avanos Medical, Inc.（纽约证券交易所代码：AVNS - 获取免费报告）在周三的交易中出现了异常强劲的交易量。当天交易了约 1,089,603 股，较前一交易日的 903,790 股增加了 21%。该股票最后交易价格为 24.6050 美元，之前收盘价为 24.63 美元。</p>
<p>获取 <strong>Avanos Medical</strong> 的提醒：</p>
<h2>更多 Avanos Medical 新闻</h2>
<p>以下是本周影响 Avanos Medical 的关键新闻：</p>
<ul>
<li>积极情绪：交易：Avanos 同意以每股 25.00 美元的现金被美国工业合作伙伴的附属公司收购，估值约为 12.7 亿美元——这是一项约 72% 的溢价，为公众股东提供了即时且确定的价值。Avanos 股票因 12.7 亿美元的 AIP 收购交易而大幅上涨，溢价 72%。</li>
<li>积极情绪：运营信号：Avanos 报告第四季度业绩超出预期（每股收益 0.29 美元，预期 0.24 美元；收入超出预期），并保留机构持有者，这支持了业务在战略交易背后基本面改善的叙述。Avanos Medical 发布第四季度业绩超出预期，机构投资者如 Armistice Capital 在非阿片类止痛设备领域持有头寸。</li>
<li>中性情绪：市场覆盖：媒体跟踪了该股票历史性的日内飙升，并总结了交易条款和时机；这只是信息性内容，但并未改变交易经济。AVNS 股票记录历史性日内飙升——关于美国工业合作伙伴的收购交易你需要知道的一切。</li>
<li>消极情绪：法律/关闭风险：多家股东律师事务所已启动调查和警报，声称与此次出售相关的潜在不公平价格或信托责任违反；诉讼或挑战可能会延迟交易完成，增加成本或施压董事会寻求更高的出价。$HAREHOLDER ALERT: M-A 集体诉讼事务所宣布对 Avanos Medical, Inc.（纽约证券交易所代码：AVNS）进行调查。</li>
</ul>
<h2>分析师评级变动</h2>
<p>几位研究分析师最近对该股票发表了看法。Zacks Research 在 1 月 26 日的研究报告中将 Avanos Medical 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 12 月 22 日的研究报告中重申了对 Avanos Medical 股票的 “卖出（d-）” 评级。最后，Wall Street Zen 在 3 月 28 日的研究报告中将 Avanos Medical 的股票评级从 “持有” 上调至 “买入”。一位研究分析师对该股票给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat，该公司的共识评级为 “减持”。</p>
<p><strong>获取我们最新的 AVNS 股票报告</strong></p>
<h2>Avanos Medical 股票表现</h2>
<p>该公司的速动比率为 1.26，流动比率为 2.15，债务与股本比率为 0.12。该公司的 50 日移动平均线为 14.27 美元，200 日移动平均线为 12.61 美元。该公司的市值为 11.4 亿美元，市盈率为-15.58，贝塔值为 1.05。</p>
<p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）最后一次发布季度财报是在 2 月 24 日。该公司报告第四季度每股收益为 0.29 美元，超出共识预期的 0.24 美元，超出 0.05 美元。Avanos Medical 的净利润率为-10.40%，股本回报率为 5.47%。该公司第四季度的收入为 1.809 亿美元，超过分析师预期的 1.747 亿美元。在去年同期，该公司每股收益为 0.43 美元。Avanos Medical 本季度的收入较去年同期增长了 0.7%。Avanos Medical 已将 2026 财年的指导目标设定为每股收益 0.900-1.100。股票分析师预计 Avanos Medical, Inc. 本财年将发布每股收益 1.32 美元。</p>
<h2>机构资金流入和流出</h2>
<p>一些机构投资者和对冲基金最近买入和卖出了 AVNS 的股票。AQR Capital Management LLC 在第一季度将其在 Avanos Medical 的持仓增加了 46.4%。AQR Capital Management LLC 目前拥有 192,864 股该公司的股票，价值 2,700,000 美元，此前在上个季度增持了 61,095 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Avanos Medical 的持仓增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前拥有 26,955 股该公司的股票，价值 386,000 美元，此前在上个季度增持了 1,121 股。Millennium Management LLC 在第一季度将其在 Avanos Medical 的持仓增加了 508.3%。Millennium Management LLC 目前拥有 547,740 股该公司的股票，价值 7,849,000 美元，此前在上个季度增持了 457,703 股。Empowered Funds LLC 在第一季度将其在 Avanos Medical 的持仓增加了 5.4%。Empowered Funds LLC 目前拥有 162,182 股该公司的股票，价值 2,324,000 美元，此前在上个季度增持了 8,348 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Avanos Medical 的持仓增加了 17.1%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前拥有 140,810 股该公司的股票，价值 2,018,000 美元，此前在上个季度增持了 20,541 股。95.17% 的股票目前由机构投资者持有。</p>
<h2>Avanos Medical 公司简介</h2>
<p>（获取免费报告）</p>
<p>Avanos Medical 是一家全球医疗技术公司，开发和销售广泛的医疗设备组合，旨在改善医院、门诊和后期护理环境中的患者结果。该公司的产品专注于三个核心治疗领域——疼痛管理、肠内喂养和呼吸护理——旨在帮助临床医生管理术后疼痛、提供营养支持并协助各种急性和慢性病症患者的呼吸。</p>
<p>在疼痛管理领域，Avanos 提供非阿片类药物输送系统和冷冻镇痛设备，包括可移动输液泵和冷却射频消融平台。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们认为比 Avanos Medical 更好的股票</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Avanos Medical 吗？</h2>
<p>在考虑 Avanos Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Avanos Medical 并不在名单上。</p>
<p>虽然 Avanos Medical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

AVNS

<p>Avanos Medical（纽约证券交易所代码：AVNS）经历了显著的交易量增加，交易量达到 1,089,603 股，比前一交易日增长 21%。该股票目前价格为 24.6050 美元。公司已同意以每股 25.00 美元的价格被美国工业合伙人收购，溢价达到 72%。尽管盈利报告积极，但关于此次出售的法律调查可能带来风险。分析师的评级意见不一，普遍评级为 “减持”。机构投资者对该股票表现出更高的兴趣，反映出对其基本面的积极展望</p>

<p>Shares of Avanos Medical, Inc. (NYSE:AVNS - Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 1,089,603 shares were traded during trading, an increase of 21% from the previous session's volume of 903,790 shares.The stock last traded at $24.6050 and had previously closed at $24.63.</p>
<div class="lb-trans"><p>Avanos Medical, Inc.（纽约证券交易所代码：AVNS - 获取免费报告）在周三的交易中出现了异常强劲的交易量。当天交易了约 1,089,603 股，较前一交易日的 903,790 股增加了 21%。该股票最后交易价格为 24.6050 美元，之前收盘价为 24.63 美元。</p>
</div><p>Get <strong>Avanos Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Avanos Medical</strong> 的提醒：</p>
</div><h2>More Avanos Medical News</h2>
<div class="lb-trans"><h2>更多 Avanos Medical 新闻</h2>
</div><p>Here are the key news stories impacting Avanos Medical this week:</p>
<div class="lb-trans"><p>以下是本周影响 Avanos Medical 的关键新闻：</p>
</div><ul>
<li>Positive Sentiment: Deal: Avanos agreed to be acquired by affiliates of American Industrial Partners for $25.00 per share in cash, valuing the company at ~ $1.27B — a ~72% premium that delivers immediate, certain value to public shareholders. Avanos Stock Surged on $1.27 Billion AIP Buyout Deal at 72% Premium</li>
<li>Positive Sentiment: Operational signal: Avanos reported a Q4 beat (EPS $0.29 vs. $0.24 est.; revenue topped estimates) and retains institutional holders, which supports the narrative that the business has improving fundamentals behind the strategic transaction. Avanos Medical Posts Q4 Beat as Institutional Investors Like Armistice Capital Hold Positions in Non-Opioid Pain Device Segment</li>
<li>Neutral Sentiment: Market coverage: Media outlets tracked the stock’s historic intraday surge and summarized deal terms and timing; this is informational but doesn’t change deal economics. AVNS stock records historic intraday surge – everything to know about the buyout deal by American Industrial Partners</li>
<li>Negative Sentiment: Legal/closing risk: Multiple shareholder-law firms have launched investigations and alerts alleging potential unfair price or fiduciary breaches related to the sale; litigation or a challenge could delay closing, increase costs or pressure the board to seek a higher bid. $HAREHOLDER ALERT: The M-A Class Action Firm Announces An Investigation of Avanos Medical, Inc. NYSE: AVNS</li>
</ul>
<div class="lb-trans"><ul>
<li>积极情绪：交易：Avanos 同意以每股 25.00 美元的现金被美国工业合作伙伴的附属公司收购，估值约为 12.7 亿美元——这是一项约 72% 的溢价，为公众股东提供了即时且确定的价值。Avanos 股票因 12.7 亿美元的 AIP 收购交易而大幅上涨，溢价 72%。</li>
<li>积极情绪：运营信号：Avanos 报告第四季度业绩超出预期（每股收益 0.29 美元，预期 0.24 美元；收入超出预期），并保留机构持有者，这支持了业务在战略交易背后基本面改善的叙述。Avanos Medical 发布第四季度业绩超出预期，机构投资者如 Armistice Capital 在非阿片类止痛设备领域持有头寸。</li>
<li>中性情绪：市场覆盖：媒体跟踪了该股票历史性的日内飙升，并总结了交易条款和时机；这只是信息性内容，但并未改变交易经济。AVNS 股票记录历史性日内飙升——关于美国工业合作伙伴的收购交易你需要知道的一切。</li>
<li>消极情绪：法律/关闭风险：多家股东律师事务所已启动调查和警报，声称与此次出售相关的潜在不公平价格或信托责任违反；诉讼或挑战可能会延迟交易完成，增加成本或施压董事会寻求更高的出价。$HAREHOLDER ALERT: M-A 集体诉讼事务所宣布对 Avanos Medical, Inc.（纽约证券交易所代码：AVNS）进行调查。</li>
</ul>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several research analysts recently weighed in on the stock. Zacks Research upgraded shares of Avanos Medical from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, January 26th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Avanos Medical in a research report on Monday, December 22nd. Finally, Wall Street Zen upgraded shares of Avanos Medical from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a research report on Saturday, March 28th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of &#34;Reduce&#34;.</p>
<div class="lb-trans"><p>几位研究分析师最近对该股票发表了看法。Zacks Research 在 1 月 26 日的研究报告中将 Avanos Medical 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 12 月 22 日的研究报告中重申了对 Avanos Medical 股票的 “卖出（d-）” 评级。最后，Wall Street Zen 在 3 月 28 日的研究报告中将 Avanos Medical 的股票评级从 “持有” 上调至 “买入”。一位研究分析师对该股票给予了 “持有” 评级，另一位则给予了 “卖出” 评级。根据 MarketBeat，该公司的共识评级为 “减持”。</p>
</div><p><strong>Get Our Latest Stock Report on AVNS</strong></p>
<div class="lb-trans"><p><strong>获取我们最新的 AVNS 股票报告</strong></p>
</div><h2>Avanos Medical Stock Performance</h2>
<div class="lb-trans"><h2>Avanos Medical 股票表现</h2>
</div><p>The company has a quick ratio of 1.26, a current ratio of 2.15 and a debt-to-equity ratio of 0.12. The company's 50-day moving average is $14.27 and its two-hundred day moving average is $12.61. The company has a market capitalization of $1.14 billion, a P/E ratio of -15.58 and a beta of 1.05.</p>
<div class="lb-trans"><p>该公司的速动比率为 1.26，流动比率为 2.15，债务与股本比率为 0.12。该公司的 50 日移动平均线为 14.27 美元，200 日移动平均线为 12.61 美元。该公司的市值为 11.4 亿美元，市盈率为-15.58，贝塔值为 1.05。</p>
</div><p>Avanos Medical (NYSE:AVNS - Get Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.05. Avanos Medical had a negative net margin of 10.40% and a positive return on equity of 5.47%. The company had revenue of $180.90 million for the quarter, compared to analysts' expectations of $174.70 million. During the same period in the prior year, the business earned $0.43 earnings per share. Avanos Medical's revenue for the quarter was up .7% compared to the same quarter last year. Avanos Medical has set its FY 2026 guidance at 0.900-1.100 EPS. Equities analysts anticipate that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Avanos Medical（纽约证券交易所代码：AVNS - 获取免费报告）最后一次发布季度财报是在 2 月 24 日。该公司报告第四季度每股收益为 0.29 美元，超出共识预期的 0.24 美元，超出 0.05 美元。Avanos Medical 的净利润率为-10.40%，股本回报率为 5.47%。该公司第四季度的收入为 1.809 亿美元，超过分析师预期的 1.747 亿美元。在去年同期，该公司每股收益为 0.43 美元。Avanos Medical 本季度的收入较去年同期增长了 0.7%。Avanos Medical 已将 2026 财年的指导目标设定为每股收益 0.900-1.100。股票分析师预计 Avanos Medical, Inc. 本财年将发布每股收益 1.32 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of AVNS. AQR Capital Management LLC grew its position in Avanos Medical by 46.4% during the first quarter. AQR Capital Management LLC now owns 192,864 shares of the company's stock valued at $2,700,000 after acquiring an additional 61,095 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Avanos Medical by 4.3% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,955 shares of the company's stock valued at $386,000 after acquiring an additional 1,121 shares during the last quarter. Millennium Management LLC grew its position in Avanos Medical by 508.3% during the first quarter. Millennium Management LLC now owns 547,740 shares of the company's stock valued at $7,849,000 after acquiring an additional 457,703 shares during the last quarter. Empowered Funds LLC grew its position in Avanos Medical by 5.4% during the first quarter. Empowered Funds LLC now owns 162,182 shares of the company's stock valued at $2,324,000 after acquiring an additional 8,348 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Avanos Medical by 17.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 140,810 shares of the company's stock valued at $2,018,000 after acquiring an additional 20,541 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近买入和卖出了 AVNS 的股票。AQR Capital Management LLC 在第一季度将其在 Avanos Medical 的持仓增加了 46.4%。AQR Capital Management LLC 目前拥有 192,864 股该公司的股票，价值 2,700,000 美元，此前在上个季度增持了 61,095 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 在第一季度将其在 Avanos Medical 的持仓增加了 4.3%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. 目前拥有 26,955 股该公司的股票，价值 386,000 美元，此前在上个季度增持了 1,121 股。Millennium Management LLC 在第一季度将其在 Avanos Medical 的持仓增加了 508.3%。Millennium Management LLC 目前拥有 547,740 股该公司的股票，价值 7,849,000 美元，此前在上个季度增持了 457,703 股。Empowered Funds LLC 在第一季度将其在 Avanos Medical 的持仓增加了 5.4%。Empowered Funds LLC 目前拥有 162,182 股该公司的股票，价值 2,324,000 美元，此前在上个季度增持了 8,348 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Avanos Medical 的持仓增加了 17.1%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前拥有 140,810 股该公司的股票，价值 2,018,000 美元，此前在上个季度增持了 20,541 股。95.17% 的股票目前由机构投资者持有。</p>
</div><h2>Avanos Medical Company Profile</h2>
<div class="lb-trans"><h2>Avanos Medical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Avanos Medical is a global medical technology company that develops and markets a broad portfolio of medical devices intended to improve patient outcomes in hospital, outpatient and post-acute care settings. The company's products focus on three core therapy areas—pain management, enteral feeding and respiratory care—designed to help clinicians manage post-operative pain, deliver nutrition support and assist breathing for patients across a variety of acute and chronic conditions.</p>
<div class="lb-trans"><p>Avanos Medical 是一家全球医疗技术公司，开发和销售广泛的医疗设备组合，旨在改善医院、门诊和后期护理环境中的患者结果。该公司的产品专注于三个核心治疗领域——疼痛管理、肠内喂养和呼吸护理——旨在帮助临床医生管理术后疼痛、提供营养支持并协助各种急性和慢性病症患者的呼吸。</p>
</div><p>In its pain management segment, Avanos offers both non-opioid drug delivery systems and cryoanalgesia devices, including ambulatory infusion pumps and cooled radiofrequency ablation platforms.</p>
<div class="lb-trans"><p>在疼痛管理领域，Avanos 提供非阿片类药物输送系统和冷冻镇痛设备，包括可移动输液泵和冷却射频消融平台。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Avanos Medical</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Avanos Medical 更好的股票</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和来自 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Avanos Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Avanos Medical 吗？</h2>
</div><p>Before you consider Avanos Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Avanos Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avanos Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Avanos Medical 并不在名单上。</p>
</div><p>While Avanos Medical currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Avanos Medical 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Avanos Medical（NYSE:AVNS）交易量强劲 - 事情是这样的